Accelerate Diagnostics (STU:1A80) Ending Cash Position : €14.42 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Accelerate Diagnostics Ending Cash Position?

Accelerate Diagnostics's Ending Cash Position for the quarter that ended in Dec. 2024 was €14.42 Mil.

Accelerate Diagnostics's quarterly Ending Cash Position increased from Jun. 2024 (€7.98 Mil) to Sep. 2024 (€17.74 Mil) but then declined from Sep. 2024 (€17.74 Mil) to Dec. 2024 (€14.42 Mil).

Accelerate Diagnostics's annual Ending Cash Position declined from Dec. 2022 (€32.95 Mil) to Dec. 2023 (€11.13 Mil) but then increased from Dec. 2023 (€11.13 Mil) to Dec. 2024 (€14.42 Mil).

Accelerate Diagnostics Ending Cash Position Historical Data

The historical data trend for Accelerate Diagnostics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerate Diagnostics Ending Cash Position Chart

Accelerate Diagnostics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

29.41

35.31

32.95

11.13

14.42

Accelerate Diagnostics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															11.13	13.44	7.98	17.74	14.42

Accelerate Diagnostics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Accelerate Diagnostics's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	11.591	+	2.828
	=	14.42

Accelerate Diagnostics's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	18.806	+	-4.387
	=	14.42

Accelerate Diagnostics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Accelerate Diagnostics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerate Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accelerate Diagnostics Inc (STU:1A80) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

AXDX:USA AXDX:Mexico 0H8E:UK 1A80:Germany

Address

3950 South Country Club Road, Suite 470, Tucson, AZ, USA, 85714

Website

https://www.acceleratediagnostics.com

Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.

Accelerate Diagnostics Headlines

No Headlines